Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2011, Article ID 215718, 16 pages
http://dx.doi.org/10.4061/2011/215718
Review Article

Thyroid Hormone and the Neuroglia: Both Source and Target

1Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, H-1083, Hungary
2Division of Endocrinology, Diabetes, and Metabolism, University of Miami Miller School of Medicine, Miami, FL 33136, USA

Received 19 March 2011; Revised 31 May 2011; Accepted 17 June 2011

Academic Editor: Juan Bernal

Copyright © 2011 Petra Mohácsik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. R. Larsen, T. F. Davies, and I. D. Hay, “The thyroid gland,” in Williams Textbook of Endocrinology, J. D. Wilson, D. W. Foster, H. M. Kronenberg, and P. R. Larsen, Eds., pp. 389–515, W.B. Saunders Co., Philadelphia, Pa, USA, 9th edition, 1998. View at Google Scholar
  2. W. M. Ord, “Report of the committee of the clinical society of london nominated December 14, 1883, to investigate the subject of myxoedema,” Transactions of the Clinical Society of London, vol. 21, supplement, pp. 1–215, 1888. View at Google Scholar
  3. J. H. Oppenheimer and H. L. Schwartz, “Molecular basis of thyroid hormone-dependent brain development,” Endocrine Reviews, vol. 18, no. 4, pp. 462–475, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Bernal, A. Guadaño-Ferraz, and B. Morte, “Perspectives in the Study of Thyroid hormone action on brain development and function,” Thyroid, vol. 13, no. 11, pp. 1005–1012, 2003. View at Google Scholar · View at Scopus
  5. G. R. Williams, “Neurodevelopmental and neurophysiological actions of thyroid hormone,” Journal of Neuroendocrinology, vol. 20, no. 6, pp. 784–794, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. R. Crantz, J. E. Silva, and P. R. Larsen, “An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum,” Endocrinology, vol. 110, no. 2, pp. 367–375, 1982. View at Google Scholar · View at Scopus
  7. J. H. Greenberg, M. Reivich, J. T. Gordon, M. B. Schoenhoff, C. S. Patlak, and M. B. Dratman, “Imaging triiodothyronine binding kinetics in rat brain: a model for studies in human subjects,” Synapse, vol. 60, no. 3, pp. 212–222, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Ceballos, M. M. Belinchon, E. Sanchez-Mendoza et al., “Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3' -triiodo-L-thyronine,” Endocrinology, vol. 150, no. 5, pp. 2491–2496, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. X.-H. Liao, C. Di Cosmo, A. M. Dumitrescu et al., “Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes,” Endocrinology, vol. 152, no. 3, pp. 1180–1191, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. I. Kakucska, W. Rand, and R. M. Lechan, “Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine,” Endocrinology, vol. 130, no. 5, pp. 2845–2850, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Davey, K. B. Becker, M. J. Schneider, D. L. S. Germain, and V. A. Galton, “Cloning of a cDNA for the type II iodothyronine deiodinase,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 26786–26789, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Salvatore, T. Bartha, J. W. Harney, and P. R. Larsen, “Molecular biological and biochemical characterization of the human type 2 selenodeiodinase,” Endocrinology, vol. 137, no. 8, pp. 3308–3315, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Croteau, J. C. Davey, V. A. Galton, and D. L. S. Germain, “Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues,” Journal of Clinical Investigation, vol. 98, no. 2, pp. 405–417, 1996. View at Google Scholar · View at Scopus
  14. B. Gereben, T. Bartha, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen, “Cloning and expression of the chicken type 2 iodothyronine 5'—deiodinase,” Journal of Biological Chemistry, vol. 274, no. 20, pp. 13768–13776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Campos-barros, T. Hoell, A. Musa et al., “Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 6, pp. 2179–2185, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. S. Germain, R. A. Schwartzman, W. Croteau et al., “A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 16, pp. 7767–7771, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Croteau, S. L. Whittemore, M. J. Schneider, and D. L. S. Germain, “Cloning and expression of a cDNA for a mammalian type III iodothyronine deiodinase,” Journal of Biological Chemistry, vol. 270, no. 28, pp. 16569–16575, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. P. N. Riskind, J. M. Kolodny, and P. R. Larsen, “The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats,” Brain Research, vol. 420, no. 1, pp. 194–198, 1987. View at Google Scholar · View at Scopus
  19. H. M. Tu, S. W. Kim, D. Salvatore et al., “Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone,” Endocrinology, vol. 138, no. 8, pp. 3359–3368, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Guadaño-Ferraz, M. J. Obregón, D. L. S. Germain, and J. Bernal, “The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 19, pp. 10391–10396, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. H. M. Tu, G. Legradi, T. Bartha, D. Salvatore, R. M. Lechan, and P. R. Larsen, “Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone,” Endocrinology, vol. 140, no. 2, pp. 784–790, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kettenmann and B. R. Ransom, Neuroglia, Oxford University Press, New York, NY, USA, 1995.
  23. B. C. G. Freitas, B. Gereben, M. Castillo et al., “Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 2206–2217, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen, “Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases,” Endocrine Reviews, vol. 23, no. 1, pp. 38–89, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Lechan and C. Fekete, “Role of thyroid hormone deiodination in the hypothalamus,” Thyroid, vol. 15, no. 8, pp. 883–897, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. Y. Wu and R. J. Koenig, “Gene regulation by thyroid hormone,” Trends in Endocrinology and Metabolism, vol. 11, no. 6, pp. 207–211, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Zhang and M. A. Lazar, “The mechanism of action of thyroid hormones,” Annual Review of Physiology, vol. 62, pp. 439–466, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. P. M. Yen, S. Ando, X. Feng, Y. Liu, P. Maruvada, and X. Xia, “Thyroid hormone action at the cellular, genomic and target gene levels,” Molecular and Cellular Endocrinology, vol. 246, no. 1-2, pp. 121–127, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. Y. Cheng, J. L. Leonard, and P. J. Davis, “Molecular aspects of thyroid hormone actions,” Endocrine Reviews, vol. 31, no. 2, pp. 139–170, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. Nunez, F. S. Celi, L. Ng, and D. Forrest, “Multigenic control of thyroid hormone functions in the nervous system,” Molecular and Cellular Endocrinology, vol. 287, no. 1-2, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Bernal, “Thyroid hormone receptors in brain development and function,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 3, pp. 249–259, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. J. Ortiz-Caro, B. Yusta, and F. Montiel, “Identification and characterization of L-triiodothyronine receptors in cells of glial and neuronal origin,” Endocrinology, vol. 119, no. 5, pp. 2163–2167, 1986. View at Google Scholar
  33. J. Puymirat, “Thyroid receptors in the rat brain,” Progress in Neurobiology, vol. 39, no. 3, pp. 281–294, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Yusta, F. Besnard, J. Ortiz-Caro, A. Pascual, A. Aranda, and L. Sarlieve, “Evidence for the presence of nuclear 3,5,3'-triiodothyronine receptors in secondary cultures of pure rat oligodendrocytes,” Endocrinology, vol. 122, no. 5, pp. 2278–2284, 1988. View at Google Scholar · View at Scopus
  35. M. Hubank, A. K. Sinha, D. Gullo, and R. P. Ekins, “Nuclear tri-iodothyronine (T3) binding in neonatal rat brain suggests a direct glial requirement for T3 during development,” Journal of Endocrinology, vol. 126, no. 3, pp. 409–415, 1990. View at Google Scholar · View at Scopus
  36. D. J. Carlson, K. A. Strait, H. L. Schwartz, and J. H. Oppenheimer, “Immunofluorescent localization of thyroid hormone receptor isoforms in glial cells of rat brain,” Endocrinology, vol. 135, no. 5, pp. 1831–1836, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. D. J. Carlson, K. A. Strait, H. L. Schwartz, and J. H. Oppenheimer, “Thyroid hormone receptor isoform content in cultured type 1 and type 2 astrocytes,” Endocrinology, vol. 137, no. 3, pp. 911–917, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. F. R. S. Lima, N. Gonçalves, F. Carvalho, A. Gomes, M. S. De Freitas, and V. M. Neto, “Thyroid hormone action on astroglial cells from distinct brain regions during development,” International Journal of Developmental Neuroscience, vol. 16, no. 1, pp. 19–27, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Manzano, J. Bernal, and B. Morte, “Influence of thyroid hormones on maturation of rat cerebellar astrocytes,” International Journal of Developmental Neuroscience, vol. 25, no. 3, pp. 171–179, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. B. Morte, J. Manzano, T. S. Scanlan, B. Vennström, and J. Bernal, “Aberrant maturation of Astrocytes in Thyroid hormone receptor α1 knockout mice reveals an interplay between Thyroid hormone receptor isoforms,” Endocrinology, vol. 145, no. 3, pp. 1386–1391, 2004. View at Publisher · View at Google Scholar · View at PubMed
  41. S.-L. Hwang, C.-L. Lin, A.-S. Lieu et al., “The expression of thyroid hormone receptor isoforms in human astrocytomas,” Surgical Neurology, vol. 70, supplement 1, pp. S1–S8, 2008. View at Publisher · View at Google Scholar · View at PubMed
  42. J. Bernal, “The significance of thyroid hormone transporters in the brain,” Endocrinology, vol. 146, no. 4, pp. 1698–1700, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. D. Braun, E. K. Wirth, and U. Schweizer, “Thyroid hormone transporters in the brain,” Reviews in the Neurosciences, vol. 21, no. 3, pp. 173–186, 2010. View at Google Scholar · View at Scopus
  44. E. C. H. Friesema, P. A. Grueters, H. Biebermann et al., “Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation,” Lancet, vol. 364, no. 9443, pp. 1435–1437, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. W. E. Visser, E. C. H. Friesema, J. Jansen, and T. J. Visser, “Thyroid hormone transport in and out of cells,” Trends in Endocrinology and Metabolism, vol. 19, no. 2, pp. 50–56, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. A. M. Dumitrescu, X. H. Liao, T. B. Best, K. Brockmann, and S. Refetoff, “A Novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene,” American Journal of Human Genetics, vol. 74, no. 1, pp. 168–175, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. C. E. Schwartz, M. M. May, N. J. Carpenter et al., “Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene,” American Journal of Human Genetics, vol. 77, no. 1, pp. 41–53, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. L. M. Roberts, K. Woodford, M. Zhou et al., “Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier,” Endocrinology, vol. 149, no. 12, pp. 6251–6261, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. E. C. H. Friesema, J. Jansen, J. W. Jachtenberg, W. E. Visser, M. H. A. Kester, and T. J. Visser, “Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10,” Molecular Endocrinology, vol. 22, no. 6, pp. 1357–1369, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. Jansen, E. C. H. Friesema, C. Milici, and T. J. Visser, “Thyroid hormone transporters in health and disease,” Thyroid, vol. 15, no. 8, pp. 757–768, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. D. Braun, A. Kinne, A. U. Brauer et al., “Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells,” GLIA, vol. 59, no. 3, pp. 463–471, 2011. View at Publisher · View at Google Scholar
  52. E. K. Wirth, S. Roth, C. Blechschmidt et al., “Neuronal 3′,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome,” Journal of Neuroscience, vol. 29, no. 30, pp. 9439–9449, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. D. L. S. Germain, A. Hernandez, M. J. Schneider, and V. A. Galton, “Insights into the role of deiodinases from studies of genetically modified animals,” Thyroid, vol. 15, no. 8, pp. 905–916, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. M. J. Schneider, S. N. Fiering, S. E. Pallud, A. F. Parlow, D. L. St Germain, and A. V. Galton, “Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4,” Molecular Endocrinology, vol. 15, no. 12, pp. 2137–2148, 2001. View at Publisher · View at Google Scholar
  55. M. J. Schneider, S. N. Fiering, B. Thai et al., “Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice,” Endocrinology, vol. 147, no. 1, pp. 580–589, 2006. View at Publisher · View at Google Scholar · View at PubMed
  56. A. Hernandez, M. E. Martinez, S. Fiering, V. A. Galton, and D. S. Germain, “Type 3 deiodinase is critical for the maturation and function of the thyroid axis,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 476–484, 2006. View at Publisher · View at Google Scholar · View at PubMed
  57. V. A. Galton, E. T. Wood, E. A. S. Germain et al., “Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development,” Endocrinology, vol. 148, no. 7, pp. 3080–3088, 2007. View at Publisher · View at Google Scholar · View at PubMed
  58. V. A. Galton, M. J. Schneider, A. S. Clark, and D. L. S. Germain, “Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases,” Endocrinology, vol. 150, no. 6, pp. 2957–2963, 2009. View at Publisher · View at Google Scholar · View at PubMed
  59. B. Morte, A. Ceballos, D. Diez et al., “Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8- and deiodinase-2-deficient mice,” Endocrinology, vol. 151, no. 5, pp. 2381–2387, 2010. View at Publisher · View at Google Scholar · View at PubMed
  60. D. L. S. Germain and V. A. Galton, “The deiodinase family of selenoproteins,” Thyroid, vol. 7, no. 4, pp. 655–668, 1997. View at Google Scholar
  61. B. Gereben and D. Salvatore, “Pretranslational regulation of type 2 deiodinase,” Thyroid, vol. 15, no. 8, pp. 855–864, 2005. View at Publisher · View at Google Scholar · View at PubMed
  62. F. Courtin, H. Zrouri, A. Lamirand et al., “Thyroid hormone deiodinases in the central and peripheral nervous system,” Thyroid, vol. 15, no. 8, pp. 931–942, 2005. View at Publisher · View at Google Scholar · View at PubMed
  63. C. Fekete and R. M. Lechan, “Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase,” Frontiers in Neuroendocrinology, vol. 28, no. 2-3, pp. 97–114, 2007. View at Publisher · View at Google Scholar · View at PubMed
  64. A. C. Bianco and B. W. Kim, “Deiodinases: implications of the local control of thyroid hormone action,” Journal of Clinical Investigation, vol. 116, no. 10, pp. 2571–2579, 2006. View at Publisher · View at Google Scholar · View at PubMed
  65. J. Kohrle, “Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination,” Best Practice and Research in Clinical Endocrinology and Metabolism, vol. 21, no. 2, pp. 173–191, 2007. View at Publisher · View at Google Scholar · View at PubMed
  66. B. Gereben, A. M. Zavacki, S. Ribich et al., “Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling,” Endocrine Reviews, vol. 29, no. 7, pp. 898–938, 2008. View at Publisher · View at Google Scholar · View at PubMed
  67. B. Gereben, A. Zeöld, M. Dentice, D. Salvatore, and A. C. Bianco, “Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences,” Cellular and Molecular Life Sciences, vol. 65, no. 4, pp. 570–590, 2008. View at Publisher · View at Google Scholar · View at PubMed
  68. D. L. St Germain, V. A. Galton, and A. Hernandez, “Miniereview: defining the roles of the lodothyronine deiodinases: current concepts and challenges,” Endocrinology, vol. 150, no. 3, pp. 1097–1107, 2009. View at Publisher · View at Google Scholar · View at PubMed
  69. G. R. Williams and J. H. Bassett, “Local control of thyroid hormone action: role of type 2 deiodinase: deiodinases: the balance of thyroid hormone,” Journal of Endocrinology, vol. 209, no. 3, pp. 261–272, 2011. View at Publisher · View at Google Scholar · View at PubMed
  70. J. Legrand, “Thyroid hormone effects on growth and development,” in Thyroid Hormone Metabolism, G. Hennemann, Ed., pp. 503–534, Marcel Dekker, New York, NY, USA, 1986. View at Google Scholar
  71. M. Bauer and P. C. Whybrow, “Thyroid hormone, neural tissue and mood modulation,” The world Journal of Biological Psychiatry, vol. 2, no. 2, pp. 59–69, 2001. View at Google Scholar
  72. R. T. Joffe and S. T. H. Sokolov, “Thyroid hormones, the brain, and affective disorders,” Critical Reviews in Neurobiology, vol. 8, no. 1-2, pp. 45–63, 1994. View at Google Scholar
  73. D. Diez, C. Grijota-Martinez, P. Agretti et al., “Thyroid hormone action in the adult brain: gene expression profiling of the effects of single and multiple doses of triiodo-L-thyronine in the rat striatum,” Endocrinology, vol. 149, no. 8, pp. 3989–4000, 2008. View at Publisher · View at Google Scholar · View at PubMed
  74. F. C. A. Gomes, C. G. Maia, J. R. L. De Menezes, and V. Moura Neto, “Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation,” GLIA, vol. 25, no. 3, pp. 247–255, 1999. View at Publisher · View at Google Scholar
  75. A. G. Trentin, “Thyroid hormone and astrocyte morphogenesis,” Journal of Endocrinology, vol. 189, no. 2, pp. 189–197, 2006. View at Publisher · View at Google Scholar · View at PubMed
  76. G. Almazan, P. Honegger, and J. M. Matthieu, “Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study,” Developmental Neuroscience, vol. 7, no. 1, pp. 45–54, 1985. View at Google Scholar
  77. F. R. S. Lima, A. Gervais, C. Colin, M. Izembart, V. M. Neto, and M. Mallat, “Regulation of microglial development: a novel role for thyroid hormone,” Journal of Neuroscience, vol. 21, no. 6, pp. 2028–2038, 2001. View at Google Scholar
  78. M. Noble, C. Pröschel, and M. Mayer-Pröschel, “Getting a GR(i)P on oligodendrocyte development,” Developmental Biology, vol. 265, no. 1, pp. 33–52, 2004. View at Publisher · View at Google Scholar
  79. J. C. Lee, M. Mayer-Proschel, and M. S. Rao, “Gliogenesis in the central nervous system,” GLIA, vol. 30, no. 2, pp. 105–121, 2000. View at Publisher · View at Google Scholar
  80. D. S. Sharlin, D. Tighe, M. E. Gilbert, and R. T. Zoeller, “The balance between oligodendrocyte and astrocyte production in major white matter tracts is linearly related to serum total thyroxine,” Endocrinology, vol. 149, no. 5, pp. 2527–2536, 2008. View at Publisher · View at Google Scholar · View at PubMed
  81. C. M. Schoonover, M. M. Seibel, D. M. Jolson et al., “Thyroid hormone regulates oligodendrocyte accumulation in developing rat brain white matter tracts,” Endocrinology, vol. 145, no. 11, pp. 5013–5020, 2004. View at Publisher · View at Google Scholar · View at PubMed
  82. J. R. Martínez-Galán, P. Pedraza, M. Santacana, F. E. Del Rey, G. M. De Escobar, and A. Ruiz-Marcos, “Early effects of iodine deficiency on radial glial cells of the hippocampus of the rat fetus. A model of neurological cretinism,” Journal of Clinical Investigation, vol. 99, no. 11, pp. 2701–2709, 1997. View at Google Scholar
  83. S. Paul, R. Poddar, and P. K. Sarkar, “Role of thyroid hormone in the morphological differentiation and maturation of astrocytes: temporal correlation with synthesis and organization of actin,” European Journal of Neuroscience, vol. 8, no. 11, pp. 2361–2370, 1996. View at Publisher · View at Google Scholar
  84. C. Faivre-Sarrailh, A. Rami, C. Fages, and M. Tardy, “Effect of thyroid deficiency on glial fibrillary acidic protein (GFAP) and GFAP-mRNA in the cerebellum and hippocampal formation of the developing rat,” Glia, vol. 4, no. 3, pp. 276–284, 1991. View at Google Scholar
  85. F. R. S. Lima, A. G. Trentin, D. Rosenthal, C. Chagas, and V. Moura Neto, “Thyroid hormone induces protein secretion and morphological changes in astroglial cells with an increase in expression of glial fibrillary acidic protein,” Journal of Endocrinology, vol. 154, no. 1, pp. 167–175, 1997. View at Google Scholar
  86. A. G. Trentin and V. M. Neto, “T3 affects cerebellar astrocyte proliferation, GFAP and fibronectin organization,” NeuroReport, vol. 6, no. 2, pp. 293–296, 1995. View at Google Scholar
  87. F. C. A. Gomes, D. Paulin, and V. M. Neto, “Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation,” Brazilian Journal of Medical and Biological Research, vol. 32, no. 5, pp. 619–631, 1999. View at Google Scholar
  88. N. J. Laping, B. Teter, N. R. Nichols, I. Rozovsky, and C. E. Finch, “Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors,” Brain Pathology, vol. 4, no. 3, pp. 259–275, 1994. View at Google Scholar
  89. M. Mallat, F. R. S. Lima, A. Gervais, C. Colin, and V. Moura Neto, “New insights into the role of thyroid hormone in the CNS: the microglial track,” Molecular Psychiatry, vol. 7, no. 1, pp. 7–8, 2002. View at Publisher · View at Google Scholar
  90. S. Garcia-Silva, G. Perez-Juste, and A. Aranda, “Cell cycle control by the thyroid hormone in neuroblastoma cells,” Toxicology, vol. 181-182, pp. 179–182, 2002. View at Publisher · View at Google Scholar
  91. J. R. Nevins, “Transcriptional regulation. A closer look at E2F,” Nature, vol. 358, no. 6385, pp. 375–376, 1992. View at Publisher · View at Google Scholar · View at PubMed
  92. M. Nygírd, G. M. Wahlström, M. V. Gustafsson, Y. M. Tokumoto, and M. Bondesson, “Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors,” Molecular Endocrinology, vol. 17, no. 1, pp. 79–92, 2003. View at Publisher · View at Google Scholar
  93. H. Furumoto, H. Ying, G. V. R. Chandramouli et al., “An unliganded thyroid hormone β receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis,” Molecular and Cellular Biology, vol. 25, no. 1, pp. 124–135, 2005. View at Publisher · View at Google Scholar · View at PubMed
  94. B. Durand, F. B. Gao, and M. Raff, “Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation,” EMBO Journal, vol. 16, no. 2, pp. 306–317, 1997. View at Publisher · View at Google Scholar · View at PubMed
  95. G. Perez-Juste and A. Aranda, “The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation,” Journal of Biological Chemistry, vol. 274, no. 8, pp. 5026–5031, 1999. View at Publisher · View at Google Scholar
  96. T. Valcana, E. R. Einstein, and J. Csejtey, “Influence of thyroid hormones on myelin proteins in the developing rat brain,” Journal of the Neurological Sciences, vol. 25, no. 1, pp. 19–27, 1975. View at Publisher · View at Google Scholar
  97. A. Compston, J. Zajicek, J. Sussman et al., “Glial lineages and myelination in the central nervous system,” Journal of Anatomy, vol. 190, part 2, pp. 161–200, 1997. View at Publisher · View at Google Scholar
  98. B. Emery, “Regulation of oligodendrocyte differentiation and myelination,” Science, vol. 330, no. 6005, pp. 779–782, 2010. View at Publisher · View at Google Scholar · View at PubMed
  99. K. A. Strait, D. J. Carlson, H. L. Schwartz, and J. H. Oppenheimer, “Transient stimulation of myelin basic protein gene expression in differentiating cultured oligodendrocytes: a model for 3,5,3'- triiodothyronine-induced brain development,” Endocrinology, vol. 138, no. 2, pp. 635–641, 1997. View at Publisher · View at Google Scholar
  100. A. Rodríguez-Peña, “Oligodendrocyte development and thyroid hormone,” Journal of Neurobiology, vol. 40, no. 4, pp. 497–512, 1999. View at Publisher · View at Google Scholar
  101. N. Ibarrola and A. Rodríguez-Peña, “Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development,” Brain Research, vol. 752, no. 1-2, pp. 285–293, 1997. View at Publisher · View at Google Scholar
  102. P. Berbel, A. Guadano-Ferraz, A. Angulo, and J. R. Cerezo, “Role of thyroid hormones in the maturation of interhemispheric connections of rats,” Behavioural Brain Research, vol. 64, no. 1-2, pp. 9–14, 1994. View at Publisher · View at Google Scholar
  103. A. Rodriguez-Pena, N. Ibarrola, M. A. Iniguez, A. Munoz, and J. Bernal, “Neonatal hypothyroidism affects the timely expression of myelin- associated glycoprotein in the rat brain,” Journal of Clinical Investigation, vol. 91, no. 3, pp. 812–818, 1993. View at Google Scholar
  104. A. G. Trentin, D. Rosenthal, and V. M. Neto, “Thyroid hormone and conditioned medium effects on astroglial cells from hypothyroid and normal rat brain: factor secretion, cell differentiation, and proliferation,” Journal of Neuroscience Research, vol. 41, no. 3, pp. 409–417, 1995. View at Publisher · View at Google Scholar · View at PubMed
  105. A. P. Farwell and S. A. Dubord-Tomasetti, “Thyroid hormone regulates the expression of laminin in the developing rat cerebellum,” Endocrinology, vol. 140, no. 9, pp. 4221–4227, 1999. View at Google Scholar
  106. A. Gonçalves Trentin, C. B. Nedel Mendes De Aguiar, R. Castilho Garcez, and M. Alvarez-Silva, “Thyroid hormone modulates the extracellular matrix organization and expression in cerebellar astrocyte: effects on astrocyte adhesion,” GLIA, vol. 42, no. 4, pp. 359–369, 2003. View at Publisher · View at Google Scholar · View at PubMed
  107. A. G. Trentin, V. Alvarez-Silva, and Moura Neto, “Thyroid hormone induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors,” American Journal of Physiology , Endocrinology and Metabolism, vol. 281, no. 5 44-5, pp. E1088–E1094, 2001. View at Google Scholar
  108. R. Martinez and F. C. A. Gomes, “Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins,” Journal of Biological Chemistry, vol. 277, no. 51, pp. 49311–49318, 2002. View at Publisher · View at Google Scholar · View at PubMed
  109. R. M. Lindsay, “Adult rat brain astrocytes support survival of both NGF-dependent and NGF-insensitive neurones,” Nature, vol. 282, no. 5734, pp. 80–82, 1979. View at Google Scholar
  110. M. Alvarez-Dolado, T. Iglesias, A. Rodríguez-Peña, J. Bernal, and A. Muñoz, “Expression of neurotrophins and the trk family of neurotrophin receptors in normal and hypothyroid rat brain,” Molecular Brain Research, vol. 27, no. 2, pp. 249–257, 1994. View at Publisher · View at Google Scholar
  111. Y. Hashimoto, S. Furukawa, F. Omae, Y. Miyama, and K. Hayashi, “Correlative regulation of nerve growth factor level and choline acetyltransferase activity by thyroxine in particular regions of infant rat brain,” Journal of Neurochemistry, vol. 63, no. 1, pp. 326–332, 1994. View at Google Scholar
  112. J. L. Leonard and A. P. Farwell, “Thyroid hormone-regulated actin polymerization in brain,” Thyroid, vol. 7, no. 1, pp. 147–151, 1997. View at Google Scholar
  113. C. A. Siegrist-Kaiser, C. Juge-Aubry, M. P. Tranter, D. M. Ekenbarger, and J. L. Leonard, “Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel, extranuclear action of thyroid hormone,” Journal of Biological Chemistry, vol. 265, no. 9, pp. 5296–5302, 1990. View at Google Scholar
  114. J. L. Leonard, “Non-genomic actions of thyroid hormone in brain development,” Steroids, vol. 73, no. 9-10, pp. 1008–1012, 2008. View at Publisher · View at Google Scholar · View at PubMed
  115. A. P. Farwell, M. P. Tranter, and J. L. Leonard, “Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes,” Endocrinology, vol. 136, no. 9, pp. 3909–3915, 1995. View at Google Scholar
  116. J. L. Leonard, M. M. Kaplan, and T. J. Visser, “Cerebral cortex responds rapidly to thyroid hormones,” Science, vol. 214, no. 4520, pp. 571–573, 1981. View at Google Scholar
  117. L. A. Burmeister, J. Pachucki, and D. L. S. Germain, “Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms,” Endocrinology, vol. 138, no. 12, pp. 5231–5237, 1997. View at Google Scholar
  118. A. Guadaño-Ferraz, M. J. Escámez, E. Rausell, and J. Bernal, “Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems,” Journal of Neuroscience, vol. 19, no. 9, pp. 3430–3439, 1999. View at Google Scholar
  119. O. Broedel, M. Eravci, S. Fuxius et al., “Effects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain,” American Journal of Physiology, Endocrinology and Metabolism, vol. 285, no. 3 48-3, pp. E470–E480, 2003. View at Google Scholar
  120. B. Anguiano, A. Quintanar, M. Luna et al., “Neuroendocrine regulation of adrenal gland and hypothalamus 5'deiodinase activity. II. Effects of splanchnicotomy and hypophysectomy,” Endocrinology, vol. 136, no. 8, pp. 3346–3352, 1995. View at Google Scholar
  121. S. Diano, F. Naftolin, F. Goglia, and T. L. Horvath, “Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus,” Endocrinology, vol. 139, no. 6, pp. 2879–2884, 1998. View at Publisher · View at Google Scholar
  122. N. M. Sanders, A. A. Dunn-Meynell, and B. E. Levin, “Third ventricular alloxan reversibly impairs glucose counterregulatory responses,” Diabetes, vol. 53, no. 5, pp. 1230–1236, 2004. View at Publisher · View at Google Scholar
  123. M. Pérez-Martín, M. Cifuentes, J. M. Grondona et al., “IGF-I stimulates neurogenesis in the hypothalamus of adult rats,” European Journal of Neuroscience, vol. 31, no. 9, pp. 1533–1548, 2010. View at Publisher · View at Google Scholar · View at PubMed
  124. R. M. Lechan and C. Fekete, “Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome,” Journal of Endocrinological Investigation, vol. 27 Suppl, no. 6, pp. 105–119, 2004. View at Google Scholar
  125. J. Faber and K. Siersbæk-Nielsen, “Serum free 3,5,3'-triiodothyronine (T3) in non-thyroidal somatic illness, as measured by ultrafiltration and immunoextraction,” Clinica Chimica Acta, vol. 256, no. 2, pp. 115–123, 1996. View at Publisher · View at Google Scholar
  126. I. J. Chopra, “Simultaneous measurement of free thyroxine and free 3,5,3'- triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome,” Thyroid, vol. 8, no. 3, pp. 249–257, 1998. View at Google Scholar
  127. M. M. Kaplan, P. R. Larsen, and F. R. Crantz, “Prevalence of abnormal thyroid function test results in patients with acute medical illnesses,” American Journal of Medicine, vol. 72, no. 1, pp. 9–16, 1982. View at Google Scholar
  128. P. R. Larsen, T. F. Davies, M.-J Schlumberger, and I. D. Hay, “hyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders,” in Williams Textbook of Endocrinology, P. R. Larsen, H. M. Kronenberg, S. Melmed, and K. S. Polonsky, Eds., pp. 331–373, W.B. Saunders Co., Philadelphia, Pa, USA, 10th edition, 2003. View at Google Scholar
  129. R. D. Utiger, “Decreased extrathyroidal triidodothyronine production in nonthyroidal illness: benefit or harm?” American Journal of Medicine, vol. 69, no. 6, pp. 807–810, 1980. View at Google Scholar
  130. L. J. de Groot, “Dangerous dogmas in medicine: the nonthyroidal illness syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 151–164, 1999. View at Publisher · View at Google Scholar
  131. B. McIver and C. A. Gorman, “Euthyroid sick syndrome: an overview,” Thyroid, vol. 7, no. 1, pp. 125–132, 1997. View at Google Scholar
  132. C. Fekete, B. Gereben, M. Doleschall et al., “Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome,” Endocrinology, vol. 145, no. 4, pp. 1649–1655, 2004. View at Publisher · View at Google Scholar · View at PubMed
  133. A. Boelen, J. Kwakkel, D. C. Thijssen-Timmer, A. Alkemade, E. Fliers, and W. M. Wiersinga, “Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice,” Journal of Endocrinology, vol. 182, no. 2, pp. 315–323, 2004. View at Publisher · View at Google Scholar
  134. C. Fekete, S. Sarkar, M. A. Christoffolete, C. H. Emerson, A. C. Bianco, and R. M. Lechan, “Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels,” Brain Research, vol. 1056, no. 1, pp. 97–99, 2005. View at Publisher · View at Google Scholar · View at PubMed
  135. E. Sánchez, P. S. Singru, C. Fekete, and R. M. Lechan, “Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone,” Endocrinology, vol. 149, no. 5, pp. 2484–2493, 2008. View at Publisher · View at Google Scholar · View at PubMed
  136. A. Lamirand, M. Ramaugé, M. Pierre, and F. Courtin, “Bacterial lipopolysaccharide induces type 2 deiodinase in cultured rat astrocytes,” Journal of Endocrinology, vol. 208, no. 2, pp. 183–192, 2011. View at Publisher · View at Google Scholar · View at PubMed
  137. A. Zeold, M. Doleschall, M. C. Haffner et al., “Characterization of the nuclear factor-κB responsiveness of the human dio2 gene,” Endocrinology, vol. 147, no. 9, pp. 4419–4429, 2006. View at Publisher · View at Google Scholar · View at PubMed
  138. E. Sánchez, P. S. Singru, G. Wittmann et al., “Contribution of TNF-α and nuclear factor-κB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration,” Endocrinology, vol. 151, no. 8, pp. 3827–3835, 2010. View at Publisher · View at Google Scholar · View at PubMed
  139. M. A. Greer and Y. Grimm, “Changes in thyroid secretion produced by inhibition of iodotyrosine deiodinase,” Endocrinology, vol. 83, no. 3, pp. 405–410, 1968. View at Google Scholar
  140. R. Peeters, C. Fekete, C. Goncalves et al., “Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency,” American Journal of Physiology, Endocrinology and Metabolism, vol. 281, no. 1 44-1, pp. E54–E61, 2001. View at Google Scholar
  141. M. J. Obregon, F. Escobar del Rey, and G. Morreale de Escobar, “The effects of iodine deficiency on thyroid hormone deiodination,” Thyroid, vol. 15, no. 8, pp. 917–929, 2005. View at Publisher · View at Google Scholar · View at PubMed
  142. E. D. Abel, R. S. Ahima, M. -E. Boers, J. K. Elmquist, and F. E. Wondisford, “Critical role for thyroid hormone receptor β2 in the regulation of paraventricular thyrotropin-releasing hormone neurons,” Journal of Clinical Investigation, vol. 107, no. 8, pp. 1017–1023, 2001. View at Google Scholar
  143. W. M. Kong, N. M. Martin, K. L. Smith et al., “Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure,” Endocrinology, vol. 145, no. 11, pp. 5252–5258, 2004. View at Publisher · View at Google Scholar · View at PubMed
  144. T. Yoshimura, S. Yasuo, M. Watanabe et al., “Light-induced hormone conversion of T4 to T3 regulates photoperiodic response of gonads in birds,” Nature, vol. 426, no. 6963, pp. 178–181, 2003. View at Publisher · View at Google Scholar · View at PubMed
  145. N. Nakao, H. Ono, T. Yamamura et al., “Thyrotrophin in the pars tuberalis triggers photoperiodic response,” Nature, vol. 452, no. 7185, pp. 317–322, 2008. View at Publisher · View at Google Scholar · View at PubMed
  146. M. Watanabe, S. Yasuo, T. Watanabe et al., “Photoperiodic regulation of type 2 deiodinase gene in djungarian hamster: possible homologies between avian and mammalian photoperiodic regulation of reproduction,” Endocrinology, vol. 145, no. 4, pp. 1546–1549, 2004. View at Publisher · View at Google Scholar · View at PubMed
  147. S. Yasuo, N. Nakao, S. Ohkura et al., “Long-day suppressed expression of type 2 deiodinase gene in the mediobasal hypothalamus of the Saanen goat, a short-day breeder: implication for seasonal window of thyroid hormone action on reproductive neuroendocrine axis,” Endocrinology, vol. 147, no. 1, pp. 432–440, 2006. View at Publisher · View at Google Scholar · View at PubMed
  148. P. Barrett, F. J. P. Ebling, S. Schuhler et al., “Hypothalamic thyroid hormone catabolism acts as a gatekeeper for the seasonal control of body weight and reproduction,” Endocrinology, vol. 148, no. 8, pp. 3608–3617, 2007. View at Publisher · View at Google Scholar · View at PubMed
  149. L. Zou, L. A. Burmeister, S. D. Styren, P. M. Kochanek, and S. T. DeKosky, “Up-regulation of type 2 iodothyronine deiodinase mRNA in reactive astrocytes following traumatic brain injury in the rat,” Journal of Neurochemistry, vol. 71, no. 2, pp. 887–890, 1998. View at Google Scholar
  150. A. Baumgartner, L. Hiedra, G. Pinna, M. Eravci, H. Prengel, and H. Meinhold, “Rat brain type II 5'-iodothyronine deiodinase activity is extremely sensitive to stress,” Journal of Neurochemistry, vol. 71, no. 2, pp. 817–826, 1998. View at Google Scholar
  151. V. A. Galton, “The roles of the iodothyronine deiodinases in mammalian development,” Thyroid, vol. 15, no. 8, pp. 823–834, 2005. View at Publisher · View at Google Scholar · View at PubMed
  152. V. J. Pop, J. L. Kuijpens, A. L. van Baar et al., “Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy,” Clinical Endocrinology, vol. 50, no. 2, pp. 147–155, 1999. View at Publisher · View at Google Scholar
  153. J. E. Haddow, G. E. Palomaki, W. C. Allan et al., “Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child,” New England Journal of Medicine, vol. 341, no. 8, pp. 549–555, 1999. View at Publisher · View at Google Scholar · View at PubMed
  154. J. Bernal and F. Pekonen, “Ontogenesis of the nuclear 3,5,3'-triiodothyronine receptor in the human fetal brain,” Endocrinology, vol. 114, no. 2, pp. 677–679, 1984. View at Google Scholar
  155. S. Chan, S. Kachilele, C. J. McCabe et al., “Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex,” Developmental Brain Research, vol. 138, no. 2, pp. 109–116, 2002. View at Publisher · View at Google Scholar
  156. M. H.A. Kester, R. Martinez De Mena, M. J. Obregon et al., “Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3117–3128, 2004. View at Publisher · View at Google Scholar · View at PubMed
  157. J. M. Bates, D. L. S. Germain, and V. A. Galton, “Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat,” Endocrinology, vol. 140, no. 2, pp. 844–851, 1999. View at Publisher · View at Google Scholar
  158. B. Gereben, J. Pachucki, A Kollár, Z. Liposits, and C. Fekete, “Expression of type 2 deiodinase in the developing chicken brain,” Thyroid, vol. 13, p. 724, 2003. View at Google Scholar
  159. T. É. H. Füzesi, E. Szabó, M. Doleschall et al., “Developmental co-expression of type 2 deiodinase (D2) and Nkx-2.1 in chicken tanycytes,” in Proceedings of the 14th International Thyroid Congress, Paris, France, 2010.
  160. F. Courtin, F. Chantoux, M. Pierre, and J. Francon, “Induction of type II 5'-deiodinase activity by cyclic adenosine 3',5'-monophosphate in cultured rat astroglial cells,” Endocrinology, vol. 123, no. 3, pp. 1577–1581, 1988. View at Google Scholar
  161. J. L. Leonard, “Dibutyryl cAMP induction of type II 5'deiodinase activity in rat brain astrocytes in culture,” Biochemical and Biophysical Research Communications, vol. 151, no. 3, pp. 1164–1172, 1988. View at Google Scholar
  162. T. Bartha, S. W. Kim, D. Salvatore et al., “Characterization of the 5'-flanking and 5'-untranslated regions of the cyclic adenosine 3',5'-monophosphate-responsive human type 2 iodothyronine deiodinase gene,” Endocrinology, vol. 141, no. 1, pp. 229–237, 2000. View at Publisher · View at Google Scholar
  163. G. Canettieri, F. S. Celi, G. Baccheschi, L. Salvatori, M. Andreoli, and M. Centanni, “Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element,” Endocrinology, vol. 141, no. 5, pp. 1804–1813, 2000. View at Publisher · View at Google Scholar
  164. B. Gereben, D. Salvatore, J. W. Harney, H. M. Tu, and P. R. Larsen, “The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1),” Molecular Endocrinology, vol. 15, no. 1, pp. 112–124, 2001. View at Publisher · View at Google Scholar
  165. S. Pallud, A. M. Lennon, M. Ramauge et al., “Expression of the type II iodothyronine deiodinase in cultured rat astrocytes is selenium-dependent,” Journal of Biological Chemistry, vol. 272, no. 29, pp. 18104–18110, 1997. View at Publisher · View at Google Scholar
  166. F. Courtin, F. Chantoux, J. M. Gavaret, D. Toru-Delbauffe, C. Jacquemin, and M. Pierre, “Induction of type II 5'-deiodinase activity in cultured rat astroglial cells by 12-O-tetradecanoylphorbol-13-acetate: dependence on glucocorticoids,” Endocrinology, vol. 125, no. 3, pp. 1277–1281, 1989. View at Google Scholar
  167. F. Courtin, J. M. Gavaret, D. Toru-Delbauffe, and M. Pierre, “Induction of 5'-deiodinase activity in rat astroglial cells by acidic fibroblast growth factor,” Developmental Brain Research, vol. 53, no. 2, pp. 237–242, 1990. View at Publisher · View at Google Scholar
  168. J. Steinsapir, J. Harney, and P. R. Larsen, “Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes,” Journal of Clinical Investigation, vol. 102, no. 11, pp. 1895–1899, 1998. View at Google Scholar
  169. J. Steinsapir, A. C. Bianco, C. Buettner, J. Harney, and P. R. Larsen, “Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center,” Endocrinology, vol. 141, no. 3, pp. 1127–1135, 2000. View at Publisher · View at Google Scholar
  170. B. Gereben, C. Goncalves, J. W. Harney, P. R. Larsen, and A. C. Bianco, “Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation,” Molecular Endocrinology, vol. 14, no. 11, pp. 1697–1708, 2000. View at Google Scholar
  171. A. Lamirand, G. Mercier, M. Ramaugé, M. Pierre, and F. Courtin, “Hypoxia stabilizes type 2 deiodinase activity in rat astrocytes,” Endocrinology, vol. 148, no. 10, pp. 4745–4753, 2007. View at Publisher · View at Google Scholar · View at PubMed
  172. G. D. V. Sagar, B. Gereben, I. Callebaut et al., “Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity,” Molecular and Cellular Biology, vol. 27, no. 13, pp. 4774–4783, 2007. View at Publisher · View at Google Scholar · View at PubMed
  173. D. Botero, B. Gereben, C. Goncalves, L. A. De Jesus, J. W. Harney, and A. C. Bianco, “Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase,” Molecular Endocrinology, vol. 16, no. 9, pp. 1999–2007, 2002. View at Publisher · View at Google Scholar
  174. B. W. Kim, A. M. Zavacki, C. Curcio-Morelli et al., “Endoplasmic reticulum-associated degradation of the human Type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2,” Molecular Endocrinology, vol. 17, no. 12, pp. 2603–2612, 2003. View at Publisher · View at Google Scholar · View at PubMed
  175. C. Curcio-Morelli, A. M. Zavacki, M. Christofollete et al., “Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation,” Journal of Clinical Investigation, vol. 112, no. 2, pp. 189–196, 2003. View at Publisher · View at Google Scholar
  176. M. Dentice, A. Bandyopadhyay, B. Gereben et al., “The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate,” Nature Cell Biology, vol. 7, no. 7, pp. 698–705, 2005. View at Publisher · View at Google Scholar · View at PubMed
  177. A. Zeöld, L. Pormüller, M. Dentice et al., “Metabolic instability of type 2 deiodinase is transferable to stable proteins independently of subcellular localization,” Journal of Biological Chemistry, vol. 281, no. 42, pp. 31538–31543, 2006. View at Publisher · View at Google Scholar · View at PubMed
  178. D. Vasiliauskas, S. Hancock, and C. D. Stern, “SWiP-1: novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development,” Mechanisms of Development, vol. 82, no. 1-2, pp. 79–94, 1999. View at Publisher · View at Google Scholar
  179. D. J. Hilton, R. T. Richardson, W. S. Alexander et al., “Twenty proteins containing a C-terminal SOCS box form five structural classes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 114–119, 1998. View at Publisher · View at Google Scholar
  180. A. M. Zavacki, R. A. E Drigo, B. C. G. Freitas et al., “The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase,” Molecular and Cellular Biology, vol. 29, no. 19, pp. 5339–5347, 2009. View at Publisher · View at Google Scholar · View at PubMed
  181. C. Fekete, B. C.G. Freitas, A. Zeöld et al., “Expression patterns of WSB-1 and USP-33 underlie cell-specific posttranslational control of type 2 deiodinase in the rat brain,” Endocrinology, vol. 148, no. 10, pp. 4865–4874, 2007. View at Publisher · View at Google Scholar · View at PubMed
  182. M. Dentice, C. Luongo, S. Huang et al., “Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 36, pp. 14466–14471, 2007. View at Publisher · View at Google Scholar · View at PubMed
  183. A. Boelen, J. Kwakkel, W. M. Wiersinga, and E. Fliers, “Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake,” Journal of Endocrinology, vol. 191, no. 3, pp. 707–714, 2006. View at Publisher · View at Google Scholar · View at PubMed
  184. W. S. Simonides, M. A. Mulcahey, E. M. Redout et al., “Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats,” Journal of Clinical Investigation, vol. 118, no. 3, pp. 975–983, 2008. View at Publisher · View at Google Scholar · View at PubMed
  185. J. D. Cahoy, B. Emery, A. Kaushal et al., “A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function,” Journal of Neuroscience, vol. 28, no. 1, pp. 264–278, 2008. View at Publisher · View at Google Scholar · View at PubMed
  186. L. A. Desouza, M. Sathanoori, R. Kapoor et al., “Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult mammalian brain,” Endocrinology, vol. 152, no. 5, pp. 1989–2000, 2011. View at Publisher · View at Google Scholar · View at PubMed